Hematology/Oncology Department
Research Studies Open for Enrollment
|
UCSF Benioff Children's Hospital Oakland Hematology/Oncology Department Research Studies Open for Enrollment |
Date: 07/19/2019 |
|---|
| Title | ID/Protocol | NCT/Phase | Sponsor | P.I. | Contact |
| A Phase 2 Study of Veliparib (ABT-888, IND # 139199) and Local Irradiation, Followed by Maintenance Veliparib and Temozolomide, in Patients with Newly Diagnosed High-Grade Glioma (HGG) without H3 K27M or BRAFV600E Mutations | ACNS1721 | NCT03581292 Phase 2 | Children's Oncology Group | Carla Golden, MD | Christine Ho (510-428-3885 x 2609) |
| Clinical/Molecular Risk-Tailored Intensive, Compressed Induction Chemotherapy Followed by Consolidation Randomization To Single-Cycle or 3 Tandem Cycles of Marrow-Ablative Chemo with Hematopoietic Progenitor Cell Rescue | Head-Start-4 | NCT02875314 Phase 4 | Next Consortium, Nationwide Children's | Joseph Torkildson, MD | Joseph Torkildson, MD |
| Genomic Analysis in Pediatric Malignancies | Genomics | N/A | N/A | Tabitha Cooney, MD | Tabitha Cooney, MD |
| H3.3.K27M specific peptide vaccine combined with poly-ILCL for the treatment of newly diagnosed HLA-A2+ H3.3K27M positive diffuse intrinsic pontine glioma and other newly diagnosed HLA-A2+ H3.3K27M positive gliomas | PNOC007 | NCT02960230 Phase 1 | Pacific Pediatric Neuro-Oncology Consortium (PNOC) | Tabitha Cooney, MD | Tabitha Cooney, MD (510-428-3885 x3398) |
| Phase 2 Study of everolimus for recurrent or progression low-grade gliomas in children | PNOC001 | NCT01734512 Phase 2 | Pacific Pediatric Neuro-Oncology Consortium (PNOC) | Joseph Torkildson, MD | Joseph Torkildson, MD |
| Prospective multi-institutional study to assess the risk of radiation induced vasculopathy and stroke as well as stroke recurrence in children with cancer who received radiation therapy to the neck and/or brain | RadART-Pro | N/A | LaRoche Family | Joseph Torkildson, MD | Joseph Torkildson, MD |